Antibe Therapeutics Inc(Pre-Merger) T.ATE

Primary Symbol: ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > An explanation please..ATE

<< Previous

Bullboard Posts

Next >>

Comment by JimmyJon Mar 11, 2021 9:08am

102 Views

Post# 32771029

RE:An explanation please..ATE

woundedknee wrote: Looking at their web site and noticed they have listed the 52 week high @ $8.90 and 52 week low @.70. Now how is this? I first thought about pre split. I was holding at the time it went to interday high of 89 cents. That makes sense. 0.89 X 10= $8.90 So how do they arrive at 70 cents for the low. This was never at 7 cents in the last year. What am I missing? tia

yahoo finance also has the 52 week low at 0.7, with 52 week high at 8.9.

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver